4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-097487
Chief Financial Officer gave up 11,891 shares (to pay taxes)
- Chief Financial Officer acquired 23,438 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bellemin Jean-Marc · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-03 | Exercise or conversion : show line 1 in the form | +23,438 | 41,239 | D | ||
| 2024-09-03 | Shares withheld for taxes : show line 2 in the form | −11,891 | $10.85 | $129,017 | 29,348 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-03 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −23,438 | 23,437 | D |
Loading xslF345X05/tm2423453-1_4seq1.xml…